Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.31 |
| ▸ | RXRA | P19793 | 1/20 | 0.31 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.31 |
| ▸ | RXRB | P28702 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | RXRG | P48443 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5606971 | 0.81 | ALDH1A1 (0.40) | ALDH1A1GABRA1TSHRGABRG2RXRA | |
| SCHEMBL701151 | 0.81 | — | — | |
| SCHEMBL5606967 | 0.81 | ALDH1A1 (0.40) | ALDH1A1GABRA1TSHRGABRG2RXRA | |
| SCHEMBL7681661 | 0.81 | — | — | |
| SCHEMBL704494 | 0.80 | ALDH1A1 (0.33) | ALDH1A1GABRA1TSHRGABRG2RXRA | |
| SCHEMBL6901108 | 0.77 | ALDH1A1 (0.32) | ALDH1A1GABRA1TSHRGABRG2RXRA | |
| SCHEMBL8013793 | 0.76 | ALDH1A1 (0.38) | ALDH1A1GABRA1TSHRGABRG2RXRA | |
| SCHEMBL6474031 | 0.74 | ALDH1A1 (0.37) | ALDH1A1GABRA1TSHRGABRG2RXRA | |
| SCHEMBL1052754 | 0.74 | ALDH1A1 (0.39) | ALDH1A1GABRA1TSHRGABRG2RXRA | |
| SCHEMBL1052747 | 0.74 | ALDH1A1 (0.39) | ALDH1A1GABRA1TSHRGABRG2RXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12036808-B2 | Ink jet recording method using temporary curing radiation | SEIKO EPSON CORPORATION (JP) | 2024-07-16 | — | — | US | disclosed |
| EP-3460013-B1 | INK JET COMPOSITION SET AND INK JET RECORDING METHOD | SEIKO EPSON CORP (JP) | 2020-08-12 | — | — | EP | disclosed |
| US-10590297-B2 | Ink jet composition set and ink jet recording method | SEIKO EPSON CORPORATION (JP) | 2020-03-17 | — | — | US | disclosed |
| EP-3470477-A1 | RADIATION-CURABLE INK JET INK COMPOSITION AND INK JET RECORDING METHOD | Seiko Epson Corporation (JP) | 2019-04-17 | — | — | EP | disclosed |
| US-20190092957-A1 | INK JET COMPOSITION SET AND INK JET RECORDING METHOD | SEIKO EPSON CORPORATION (JP) | 2019-03-28 | — | — | US | disclosed |
| EP-3460013-A1 | INK JET COMPOSITION SET AND INK JET RECORDING METHOD | Seiko Epson Corporation (JP) | 2019-03-27 | — | — | EP | disclosed |
| US-9925801-B2 | Ink jet recording method, ultraviolet curable ink, and ink jet recording apparatus | SEIKO EPSON CORPORATION (JP) | 2018-03-27 | — | — | US | disclosed |
| US-9873808-B2 | Ultraviolet-curable ink jet ink composition | SEIKO EPSON CORPORATION (JP) | 2018-01-23 | — | — | US | disclosed |
| US-9827760-B2 | Ink jet recording method and ink jet recording apparatus | SEIKO EPSON CORPORATION (JP) | 2017-11-28 | — | — | US | disclosed |
| US-9796193-B2 | Ink jet recording method, ultraviolet curable ink and ink jet recording apparatus | SEIKO EPSON CORPORATION (JP) | 2017-10-24 | — | — | US | disclosed |
| US-20120147095-A1 | INK COMPOSITION FOR ULTRAVIOLET CURABLE INK JETS, INK JET RECORDING APPARATUS USING THE SAME, INK JET RECORDING METHOD USING THE SAME, AND INK SET | SEIKO EPSON CORPORATION (JP) | 2012-06-14 | — | — | US | disclosed |
| US-8192804-B2 | Photocurable ink composition, ink jet recording method, and recording matter | SEIKO EPSON CORPORATION (JP) | 2012-06-05 | — | — | US | disclosed |
| US-20120133059-A1 | RADIATION CURABLE INK JET COMPOSITION, RECORDED MATTER, AND INK JET RECORDING METHOD | SEIKO EPSON CORPORATION (JP) | 2012-05-31 | — | — | US | disclosed |
| US-8158214-B2 | Photocurable ink composition set, ink jet recording method, and recorded matter | SEIKO EPSON CORPORATION (JP) | 2012-04-17 | — | — | US | disclosed |
| US-20110195249-A1 | ADHESIVE COMPOSITION AND OPTICAL MEMBER | Wuxi Hengxin Optoelectronic Materials Co., Ltd. (CN) | 2011-08-11 | — | — | US | disclosed |
| US-20100310835-A1 | Coating Agent for Plastic Label, and Plastic Label | FUJI SEAL INTERNATIONAL, INC. (JP) | 2010-12-09 | — | — | US | disclosed |
| US-7763686-B2 | Having a narrow molecular weight distribution in a short amount of time and with good productivity by mixing a first Lewis acid with a proton source to generate initiator cations, and adding a vinyl ether and a second Lewis acid to initiate a high-speed polymerization | CANON KABUSHIKI KAISHA (JP) | 2010-07-27 | — | — | US | disclosed |
| US-20090041946-A1 | Photocuable Ink Composition Set, Ink Jet Recording Method, and Recorded Matter | SEIKO EPSON CORPORATION (JP) | 2009-02-12 | — | — | US | disclosed |
| US-20070049768-A1 | COMPOSITION OF VINYL ETHER GROUP CONTAINING (METH) ACRYLIC ACID ESTER AND PRODUCTION METHOD THEREOF | NIPPON SHOKUBAI CO., LTD. (JP) | 2007-03-01 | — | — | US | disclosed |
| US-20060194935-A1 | Process for producing polyalkenyl ether | CANON KABUSHIKI KAISHA (JP) | 2006-08-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070049768-A1 | COMPOSITION OF VINYL ETHER GROUP CONTAINING (METH) ACRYLIC ACID ESTER AND PRODUCTION METHOD THEREOF | MMAB, ME1, PRMT1 | ALDH1A1 79/4885GABRA1 578/4885TSHR 2551/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.